TSE:NVCN Neovasc (NVCN) Stock Price, News & Analysis → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free NVCN Stock Alerts Add Compare Share Share Today's Range N/A50-Day RangeC$40.15▼C$40.1552-Week Range N/AVolume399 shsAverage Volume2,123 shsMarket CapitalizationC$110.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Neovasc alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Neovasc Stock (TSE:NVCN)Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.Read More Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now NVCN Stock News HeadlinesFebruary 14, 2024 | investing.comAptose Biosciences Inc (APS)April 6, 2023 | theglobeandmail.comClosing Bell: Neovasc Inc up on Thursday (NVCN)May 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 1, 2023 | theglobeandmail.comNeovasc: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (NVCN)January 17, 2023 | finance.yahoo.comShockwave Medical to Acquire NeovascJanuary 17, 2023 | marketwatch.comShockwave Medical to Buy Neovasc for $75 MillionJanuary 17, 2023 | benzinga.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Neovasc Inc. (NVCN)November 11, 2022 | seekingalpha.comNeovasc Inc. (NVCN) Q3 2022 Earnings Call TranscriptMay 9, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.November 8, 2022 | finance.yahoo.comNeovasc Reducer Obtains U.S. Outpatient ReimbursementOctober 30, 2022 | finance.yahoo.comNeovasc Inc. (NVCN)September 20, 2022 | finance.yahoo.comNeovasc Provides Corporate Update Following Clinical Data ReleaseSeptember 16, 2022 | finance.yahoo.comNeovasc to Participate in LSI Europe 2022 Emerging MedTech SummitSeptember 15, 2022 | reuters.comNVCN.TO - Neovasc Inc | Stock Price & Latest News | ReutersAugust 30, 2022 | finance.yahoo.comNeovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceAugust 11, 2022 | seekingalpha.comNeovasc Inc. (NVCN) CEO Fred Colen on Q2 2022 Results - Earnings Call TranscriptJuly 28, 2022 | finance.yahoo.comNeovasc to Report Second Quarter Financial Results on August 11, 2022July 26, 2022 | marketwatch.comNeovasc Says FDA Approves Protocol Supplement for Angina StudyJuly 26, 2022 | finance.yahoo.comNeovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient PopulationsJuly 5, 2022 | ca.finance.yahoo.comStocks in play: Neovasc IncJune 8, 2022 | finance.yahoo.comNeovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor ConferenceMay 23, 2022 | finance.yahoo.comNeovasc to Participate in H.C. Wainwright Global Investment ConferenceMay 13, 2022 | apnews.comNeovasc Announces First Quarter Financial Results and Provides Corporate UpdateMay 13, 2022 | seekingalpha.comNeovasc Inc. (NVCN) CEO Fred Colen on Q1 2022 Results - Earnings Call TranscriptMay 11, 2022 | seekingalpha.comNeovasc Q1 Earnings PreviewApril 29, 2022 | finance.yahoo.comNeovasc to Report First Quarter Financial Results on May 12, 2022April 20, 2022 | finance.yahoo.comNeovasc to Participate in Bloom Burton & Co. Healthcare Investment ConferenceSee More Headlines Receive NVCN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryN/A Current SymbolTSE:NVCN CUSIPN/A CIKN/A Webwww.neovasc.com Phone16042704344FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($20.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-33,520,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-78.25% Return on Assets-32.95% Debt Debt-to-Equity Ratio44.86 Current Ratio8.44 Quick Ratio8.04 Sales & Book Value Annual SalesC$3.11 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.05 Book ValueC$10.22 per share Price / BookN/AMiscellaneous Outstanding Shares2,760,000Free FloatN/AMarket CapC$110.81 million OptionableNot Optionable Beta2.01 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Fredericus A. Colen (Age 71)Pres, CEO & Director Comp: $2.59MMr. Christopher Clark B.A. (Age 51)BA (Honours), C.A., CA, PgD, CFO & Corp. Sec. Comp: $1.42MMr. William Reed Little (Age 52)Chief Operating Officer Comp: $1.2MMr. John Christopher Panton (Age 56)Chief Quality Officer Comp: $505.88kSarah Marie-Hodgson GallagherVP of Clinical AffairsKey CompetitorsRMP EnergyTSE:RMPBrightPath Early LearningCVE:BPE298835 (GBU.TO)TSE:GBUWesternZagros Resources ULC,CVE:WZR812575 (SGF.TO)TSE:SGFView All Competitors NVCN Stock Analysis - Frequently Asked Questions How do I buy shares of Neovasc? Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVCN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neovasc Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
